Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,701 | 335 | 99.8% |
| Education | $13.89 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $747.33 | 50 | $0 (2024) |
| ABBVIE INC. | $581.52 | 42 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $479.07 | 25 | $0 (2024) |
| Lilly USA, LLC | $459.79 | 29 | $0 (2024) |
| PFIZER INC. | $417.25 | 25 | $0 (2024) |
| Novo Nordisk Inc | $328.20 | 18 | $0 (2024) |
| Astellas Pharma US Inc | $246.53 | 14 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $238.35 | 13 | $0 (2024) |
| Abbott Laboratories | $231.00 | 10 | $0 (2024) |
| Amgen Inc. | $220.32 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,263 | 65 | ABBVIE INC. ($218.67) |
| 2023 | $1,450 | 85 | GlaxoSmithKline, LLC. ($224.13) |
| 2022 | $809.37 | 50 | GlaxoSmithKline, LLC. ($139.16) |
| 2021 | $1,053 | 63 | GlaxoSmithKline, LLC. ($183.51) |
| 2020 | $220.54 | 13 | GlaxoSmithKline, LLC. ($56.52) |
| 2019 | $422.32 | 27 | Lilly USA, LLC ($73.79) |
| 2018 | $318.67 | 21 | Novo Nordisk Inc ($54.14) |
| 2017 | $178.81 | 12 | AstraZeneca Pharmaceuticals LP ($57.37) |
All Payment Transactions
336 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/10/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $3.90 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/09/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $3.61 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $0.64 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | Noven Therapeutics, LLC | Xelstrym (Drug) | Food and Beverage | In-kind items and services | $23.05 | General |
| Category: ADHD | ||||||
| 11/22/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $9.11 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: RESPIRATORY | ||||||
| 10/28/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: PAIN | ||||||
| 10/22/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: Respiratory | ||||||
| 10/10/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/17/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.18 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Neurology | ||||||
| 09/04/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: Endocrinology | ||||||
| 09/03/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: Obesity | ||||||
| 08/28/2024 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $64.29 | General |
| Category: Neuromodulation | ||||||
| 08/28/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: Oncology | ||||||
| 08/15/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $23.27 | General |
| Category: Diabetes | ||||||
| 07/31/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $25.47 | General |
| Category: Cardio-renal | ||||||
| 07/30/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: PAIN | ||||||
| 07/24/2024 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: Neurology | ||||||
| 07/23/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.01 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 2,005 | 2,508 | $450,509 | $166,094 |
| 2022 | 20 | 2,053 | 2,551 | $419,977 | $170,493 |
| 2021 | 20 | 1,758 | 2,208 | $247,521 | $156,321 |
| 2020 | 20 | 1,848 | 2,298 | $225,944 | $134,088 |
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 443 | 903 | $235,144 | $71,371 | 30.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 343 | 343 | $90,672 | $42,388 | 46.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 109 | 130 | $23,960 | $7,461 | 31.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 97 | 98 | $14,145 | $7,036 | 49.7% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 342 | 342 | $13,118 | $6,016 | 45.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 21 | 21 | $11,995 | $5,912 | 49.3% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 300 | 300 | $11,507 | $5,277 | 45.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 27 | 27 | $9,093 | $4,268 | 46.9% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 22 | 22 | $9,207 | $3,426 | 37.2% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 19 | 19 | $6,418 | $3,010 | 46.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 98 | 99 | $6,242 | $2,923 | 46.8% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 35 | 37 | $3,975 | $2,123 | 53.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $7,439 | $1,950 | 26.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 31 | 31 | $1,954 | $914.81 | 46.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 18 | 21 | $2,254 | $800.72 | 35.5% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 12 | 23 | $1,961 | $664.22 | 33.9% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 14 | 15 | $495.90 | $243.00 | 49.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 24 | 24 | $711.36 | $207.43 | 29.2% |
| 81002 | Urinalysis, manual test | Office | 2023 | 28 | 31 | $215.76 | $105.71 | 49.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 422 | 872 | $209,886 | $71,454 | 34.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 322 | 322 | $77,274 | $40,686 | 52.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 129 | 129 | $16,837 | $8,779 | 52.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 52 | 52 | $17,276 | $8,384 | 48.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 123 | 137 | $23,084 | $7,671 | 33.2% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 334 | 334 | $12,004 | $6,027 | 50.2% |
About Dr. Ralph Sharman, M.D
Dr. Ralph Sharman, M.D is a Family Medicine healthcare provider based in Dripping Springs, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1548297096.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ralph Sharman, M.D has received a total of $5,715 in payments from pharmaceutical and medical device companies, with $1,263 received in 2024. These payments were reported across 336 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($5,701).
As a Medicare-enrolled provider, Sharman has provided services to 7,664 Medicare beneficiaries, totaling 9,565 services with total Medicare billing of $626,997. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Dripping Springs, TX
- Active Since 06/27/2006
- Last Updated 04/19/2018
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1548297096
Products in Payments
- TRELEGY ELLIPTA (Drug) $529.38
- JARDIANCE (Drug) $334.91
- UBRELVY (Drug) $251.51
- FARXIGA (Drug) $203.51
- VRAYLAR (Drug) $189.16
- MOUNJARO (Drug) $183.90
- XARELTO (Drug) $162.10
- NURTEC ODT (Drug) $150.73
- Cologuard Collection Kit (Device) $133.06
- TRINTELLIX (Drug) $130.18
- MYRBETRIQ (Drug) $128.80
- Kerendia (Drug) $118.07
- APLENZIN (Drug) $116.30
- AREXVY (Drug) $115.15
- Vascepa (Drug) $109.96
- QULIPTA (Drug) $109.26
- Wegovy (Drug) $106.86
- ELIQUIS (Drug) $101.05
- Rybelsus (Drug) $96.98
- Otezla (Drug) $89.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Dripping Springs
Kevin Lewis, D.o, D.O
Family Medicine — Payments: $14,898
William Noble, Md, MD
Family Medicine — Payments: $3,157
Celeste Pitts, Fnp, FNP
Family Medicine — Payments: $922.41
Dr. Cameron Kielhorn, D.o, D.O
Family Medicine — Payments: $377.56
Todd Buchanan, M.d, M.D
Family Medicine — Payments: $111.80
Robert Norris, Md, MD
Family Medicine — Payments: $68.57